Le Lézard
Classified in: Health
Subject: PER

MCRA Hires Bonnie Clothier, PhD, RN, Associate Director, Payor Relations, to Further Expand Reimbursement Payor Relations Service Division


WASHINGTON, July 19, 2018 /PRNewswire/ -- Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA), a leading advisory firm and Clinical Research Organization (CRO) to the medical device industry, is pleased to announce the recent hire of Bonnie Clothier, PhD, RN, as its Associate Director, Payor Relations, to further expand its medical technology reimbursement payor relations expertise and service offerings.

MCRA Logo (PRNewsFoto/MCRA)

Ms. Clothier most recently worked for Independence Blue Cross where she was responsible for reviewing and updating medical policy coverage positions, providing clinical rationale for appropriateness of medical billing codes (ICD10, CPT and HCPCS),  and analyzing utilization patterns of claims data.  

In her role at MCRA, Ms. Clothier will be responsible for providing internal and customer support to help identify specific payor issues and develop plans for gaining or improving U.S. coverage with health plans for new and innovative technologies.

Ms. Clothier said, "I am honored to join a talented, dynamic firm where I can leverage my private payor experience with my clinical and research background to assist MCRA's clients with successfully obtaining covered access to evidenced-based care."

Tim Hunter, MCRA's Vice President of Health Economics, Reimbursement, and Public Policy said, "MCRA has a long history of working with payors to help them understand the important role and benefits of innovative medical devices and their associated procedures. We are excited that Bonnie has joined our Payor Relations team; with her combination of clinical and commercial insurance experience she will expand our ability to provide patient access to appropriate medical care."

For more information on MCRA, please visit www.mcra.com

About MCRA
Founded in 2004, Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) is a leading adviser and clinical research organization to the neuro-musculoskeletal and orthopedic industry. MCRA's value lies in its industry experience and integration of five business value creators: regulatory, reimbursement, clinical research, healthcare compliance and quality assurance. MCRA's integrated approach of these key value creating initiatives provides unparalleled expertise for its clients. MCRA has offices in Washington, DC, Manchester, CT and New York, NY, and serves nearly 500 clients globally. MCRA has a demonstrated history of driving success in all areas of the medical device industry including spine, orthopedics, cardio-vascular, diagnostic imaging, endoscopy, ophthalmics, general/plastic surgery, drug delivery, wound care, diabetes, dental, general healthcare, nephrology, neurology, cardiology, and in vitro diagnostic (IVD) devices.

Contact
David W. Lown
General Manager, MCRA, LLC
Phone: 212.583.0250 ext. 2111
Email: [email protected]

SOURCE Musculoskeletal Clinical Regulatory Advisers, LLC


These press releases may also interest you

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...



News published on and distributed by: